|
ISG20L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.767990E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.040400E-01 |
| Normal-vs-Stage2 |
3.130200E-01 |
| Normal-vs-Stage3 |
4.944600E-03 |
| Normal-vs-Stage4 |
9.59219999999705E-05 |
| Stage1-vs-Stage2 |
4.566000E-01 |
| Stage1-vs-Stage3 |
1.014450E-02 |
| Stage1-vs-Stage4 |
7.647300E-04 |
| Stage2-vs-Stage3 |
2.981800E-01 |
| Stage2-vs-Stage4 |
6.274500E-02 |
| Stage3-vs-Stage4 |
3.677200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.640100E-02 |
| Normal-vs-AfricanAmerican |
3.974000E-02 |
| Normal-vs-Asian |
8.494400E-01 |
| Caucasian-vs-AfricanAmerican |
2.673000E-01 |
| Caucasian-vs-Asian |
7.404600E-01 |
| AfricanAmerican-vs-Asian |
5.053000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.295300E-03 |
| Normal-vs-Female |
5.869600E-01 |
| Male-vs-Female |
1.937930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.265180E-01 |
| Normal-vs-Age(41-60Yrs) |
6.145800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.389600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.393400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.208800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.504400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.122200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.981600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.458000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.937800E-01 |
| Normal-vs-Grade 2 |
7.497600E-01 |
| Normal-vs-Grade 3 |
1.638710E-03 |
| Normal-vs-Grade 4 |
3.609100E-04 |
| Grade 1-vs-Grade 2 |
1.913350E-01 |
| Grade 1-vs-Grade 3 |
2.613800E-02 |
| Grade 1-vs-Grade 4 |
5.456300E-03 |
| Grade 2-vs-Grade 3 |
3.115700E-03 |
| Grade 2-vs-Grade 4 |
7.957300E-04 |
| Grade 3-vs-Grade 4 |
2.802800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.828200E-01 |
| Normal-vs-ccB subtype |
1.900590E-03 |
| ccA subtype-vs-ccB subtype |
4.08040000000609E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.677700E-02 |
| Normal-vs-N1 |
5.908600E-01 |
| N0-vs-N1 |
9.398200E-01 |
|
|
